Roblox founder and CEO David Baszucki and his wife have donated $6.2m to develop a new software platform that could revolutionise the study and treatment of...
Heart attacks could soon be diagnosed faster and more accurately thanks to a new test developed with artificial intelligence. It’s hoped the UK-led breakthrough could reduce...
South Korean scientists have made a potentially groundbreaking discovery that could change how Alzheimer’s disease is diagnosed and treated. The team from the Center for Cognition...
A new twist on a drug used to treat alcohol use disorder could double up as a treatment for stroke. Carb – short for Carbamathione –...
US biotech Alzamend Neuro has started a first of its kind phase 1/2a trial of an immunotherapy vaccine aimed at helping patients suffering with mild-to-moderate Alzheimer’s...
New results from a large 10-year study show fall risk and incidence in older adults can be significantly reduced through a modest amount of a particular...
Digital health company, NeuroRPM, has received FDA clearance for its artificial intelligence (AI)-powered remote monitoring app for Parkinson’s disease. The product uses AI and Apple Watch...
A new spectroscopy probe, with optical fibres to provide real-time information to doctors, could enhance deep brain stimulation procedure for Parkinson’s disease patients. Deep brain stimulation...
The UK Government has named two leaders in dementia research to spearhead its ambitious national Mission to tackle dementia, launched in memory of the late Dame...
BlueRock Therapeutics will leverage a data platform from software company Rune Labs to monitor Parkinson’s disease patients in a new observational study. BlueRock will use StriveStudy,...
